Simulations Plus, Inc. (Nasdaq: SLP) stands as a prominent supplier of modeling and simulation software and advisory services that bolster drug discovery, research in development, and regulatory submissions. Together with our affiliates, Cognigen, DILIsym Services, and Lixoft, we provide solutions that meld machine learning, physiologically based biopharmaceutics/pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches.